sur ONWARD MEDICAL NV (isin : NL0015000HT4)
Advancements in Blood Pressure Regulation Using ONWARD ARC-IM Therapy
ONWARD Medical has announced concurrent publications in Nature and Nature Medicine, revealing significant progress in blood pressure control after spinal cord injury using the ARC-IM Therapy. Clinical studies demonstrated immediate improvement in blood pressure stability and reduced hypotensive symptoms, leading to enhanced quality of life for participants.
Blood pressure instability is prevalent among spinal cord injury patients, with many experiencing chronic orthostatic hypotension and autonomic dysreflexia. Studies indicated that ARC-IM Therapy targets the "Hemodynamic Hotspot" of the spinal cord for precise stimulation, offering potential solutions for persistent blood pressure issues.
ONWARD Medical plans to initiate the Empower BP global pivotal trial to further assess the therapy's efficacy. This development marks a crucial step towards addressing the unmet needs of individuals with spinal cord injuries.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ONWARD MEDICAL NV